ALKS — Alkermes plc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1520262 ·
Last close
$51.94
Market Cap
$8.66B
52W High
$55.67
52W Low
$32.76
ADV30
2,563,841
Next earnings
2026-07-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 392,911,000 | 331,333,000 | -48,280,000 | -66,480,000 | 4,258,076,000 | 351,551,000 | 2,506,545,000 |
| Dec 2025 | 384,547,000 | 338,338,000 | 58,104,000 | 49,341,000 | 2,486,993,000 | 388,570,000 | 667,698,000 |
| Sep 2025 | 394,185,000 | 342,594,000 | 89,082,000 | 82,761,000 | 2,329,512,000 | 616,449,000 | 596,080,000 |
| Jun 2025 | 390,657,000 | 341,197,000 | 92,978,000 | 87,098,000 | 2,252,809,000 | 521,199,000 | 628,225,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$256,200,000
Investing CF
$-1,790,605,000
Financing CF
$1,486,151,000
CapEx
$-44,530,000
Dividends Paid
—
Buybacks
$-27,696,000
EPS Diluted TTM
$0.90
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-801,274,000
Inventory
$336,703,000
Receivables
$407,630,000
ST Investments
$160,311,000
EBIT TTM
$237,204,000
Pretax Income TTM
$204,035,000
Interest Exp TTM
$33,169,000
Analysts
17
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,562,300,032
EBITDA
$278,583,008
Free Cash Flow
$140,551,632
Enterprise Value
$10,033,623,040
Total Cash
$511,862,016
Total Debt
$1,581,660,032
Shares Out
166,675,807
Trailing EPS
$0.90
Book Value
$10.52
ROE
9.4%
ROA
4.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,475,899,000 | 253,956,000 | 241,664,000 | 2,486,993,000 | 667,698,000 | — | 520,754,000 |
| Dec 2024 | 1,557,632,000 | 420,636,000 | 367,070,000 | 2,055,567,000 | 590,590,000 | — | 439,124,000 |
| Dec 2023 | 1,663,405,000 | 414,122,000 | 355,757,000 | 2,136,223,000 | 933,537,000 | — | 401,353,000 |
| Dec 2022 | 1,111,795,000 | -6,089,000 | -158,267,000 | 1,963,978,000 | 920,225,000 | — | 21,044,000 |
TTM Snapshot
Revenues TTM
$399,082,000
NetIncome TTM
$-105,686,000
OpCashFlow TTM
$0
Assets (Latest)
$1,797,227,000
Forward EPS
$1.56
Max Pain — expiry 2026-08-21
max pain strike: $45.00 · spot: $51.94 · call oi: 6,866 · put oi: 5,549
Expected Move to 2026-08-21:
±$6.97
(13.43%) —
implied range
$44.96 –
$58.91
· ATM straddle on $50.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TGTX | TG THERAPEUTICS, INC. | $8.74B | $57.12 | — |
| SYRE | Spyre Therapeutics, Inc. | $8.49B | $97.74 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | $8.85B | $83.58 | — |
| PTGX | Protagonist Therapeutics, Inc | $8.45B | $131.42 | — |
| PRAX | Praxis Precision Medicines, Inc. | $9.06B | $324.99 | — |
News headlines (Yahoo Finance, 1h cache)
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
2026-07-03 11:06 · Yahoo
Alkermes (ALKS) Is Up 9.3% After Strong Alixorexton Phase 2 Data And Russell 2000 Addition - What's Changed
2026-06-30 14:07 · Yahoo
Sector Update: Healthcare Stocks Higher Late Afternoon
2026-06-29 19:59 · Yahoo
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
2026-06-29 17:41 · Yahoo
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
2026-06-29 17:40 · Yahoo
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
2026-06-29 16:01 · Yahoo
Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says
2026-06-29 15:14 · Yahoo
Adobe downgraded, Roblox upgraded: Wall Street's top analyst calls
2026-06-29 13:44 · Yahoo
Here Are Monday’s Best Wall Street Analyst Research Calls: Adobe, Applovin, Casey’s General Stores, CrowdStrike, Honeywell Aerospace, Salesforce, Synaptics, Terawulf, and More
2026-06-29 12:21 · Yahoo
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
2026-06-26 09:46 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.